Yayun Yan1, Yanyan Cao1,2, Rong Cheng1, Zhizhong Shen1, Yajing Zhao1, Yixia Zhang3, Guohong Zhou4, Shengbo Sang5. 1. MicroNano System Research Center, College of Information and Computer & Key Lab of Advanced Transducers and Intelligent Control System, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, China. 2. College of Information Science and Engineering, Hebei North University, Zhangjiakou, 075000, China. 3. College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China. 4. Department of Lacrimal Duct Diseases, Shanxi Eye Hospital, Taiyuan, 030002, China. 5. MicroNano System Research Center, College of Information and Computer & Key Lab of Advanced Transducers and Intelligent Control System, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, China. sunboa-sang@tyut.edu.cn.
Abstract
BACKGROUND: Corneal disease is second only to cataract considered as the leading cause of blindness in the world, with high morbidity. Construction of corneal substitutes in vitro by tissue engineering technology to achieve corneal regeneration has become a research hotspot in recent years. We conducted in-depth research on the biocompatibility, physicochemical and mechanical properties of rat bone marrow mesenchymal stem cells (rBM-MSCs)-seeded gelatin methacrylate (GelMA) as a bioengineered cornea. METHODS: Four kinds of GelMA with different concentrations (7, 10, 15 and 30%) were prepared, and their physic-chemical, optical properties, and biocompatibility with rBM-MSCs were characterized. MTT, live/dead staining, cell morphology, immunofluorescence staining and gene expression of keratocyte markers were performed. RESULTS: 7%GelMA hydrogel had higher equilibrium water content and porosity, better optical properties and hydrophilicity. In addition, it is more beneficial to the growth and proliferation of rBM-MSCs. However, the 30%GelMA hydrogel had the best mechanical properties, and could be more conducive to promote the differentiation of rBM-MSCs into keratocyte-like cells. CONCLUSION: As a natural biological scaffold, GelMA hydrogel has good biocompatibility. And it has the ability to promote the differentiation of rBM-MSCs into keratocyte-like cells, which laid a theoretical and experimental foundation for further tissue-engineered corneal stromal transplantation, and provided a new idea for the source of seeded cells in corneal tissue engineering.
BACKGROUND: Corneal disease is second only to cataract considered as the leading cause of blindness in the world, with high morbidity. Construction of corneal substitutes in vitro by tissue engineering technology to achieve corneal regeneration has become a research hotspot in recent years. We conducted in-depth research on the biocompatibility, physicochemical and mechanical properties of rat bone marrow mesenchymal stem cells (rBM-MSCs)-seeded gelatin methacrylate (GelMA) as a bioengineered cornea. METHODS: Four kinds of GelMA with different concentrations (7, 10, 15 and 30%) were prepared, and their physic-chemical, optical properties, and biocompatibility with rBM-MSCs were characterized. MTT, live/dead staining, cell morphology, immunofluorescence staining and gene expression of keratocyte markers were performed. RESULTS: 7%GelMA hydrogel had higher equilibrium water content and porosity, better optical properties and hydrophilicity. In addition, it is more beneficial to the growth and proliferation of rBM-MSCs. However, the 30%GelMA hydrogel had the best mechanical properties, and could be more conducive to promote the differentiation of rBM-MSCs into keratocyte-like cells. CONCLUSION: As a natural biological scaffold, GelMA hydrogel has good biocompatibility. And it has the ability to promote the differentiation of rBM-MSCs into keratocyte-like cells, which laid a theoretical and experimental foundation for further tissue-engineered corneal stromal transplantation, and provided a new idea for the source of seeded cells in corneal tissue engineering.
Authors: A I Van Den Bulcke; B Bogdanov; N De Rooze; E H Schacht; M Cornelissen; H Berghmans Journal: Biomacromolecules Date: 2000 Impact factor: 6.988
Authors: Che Man Rohaina; Kong Yong Then; Angela Min Hwei Ng; Wan Haslina Wan Abdul Halim; Aida Zairani Mohd Zahidin; Aminuddin Saim; Ruszymah B H Idrus Journal: Transl Res Date: 2013-11-08 Impact factor: 7.012
Authors: Muhammad Rizwan; Gary S L Peh; Heng-Pei Ang; Nyein Chan Lwin; Khadijah Adnan; Jodhbir S Mehta; Wui Siew Tan; Evelyn K F Yim Journal: Biomaterials Date: 2016-12-23 Impact factor: 12.479
Authors: Young In Yun; Se Yeon Park; Hyun Ju Lee; Jung Hwa Ko; Mee Kum Kim; Won Ryang Wee; Roxanne L Reger; Carl A Gregory; Hosoon Choi; Samuel F Fulcher; Darwin J Prockop; Joo Youn Oh Journal: Cytotherapy Date: 2016-11-10 Impact factor: 5.414
Authors: Tugce A Arica; Meltem Guzelgulgen; Ahu Arslan Yildiz; Mustafa M Demir Journal: Mater Sci Eng C Mater Biol Appl Date: 2020-11-13 Impact factor: 7.328
Authors: N E Vrana; N Builles; H Kocak; P Gulay; V Justin; M Malbouyres; F Ruggiero; O Damour; V Hasirci Journal: J Biomater Sci Polym Ed Date: 2007 Impact factor: 3.517